In 2025, the mannan-oligosaccharides (MOS) market surpassed a value of USD 465.0 million. Based on Future Market Insights’ analysis, demand is estimated to grow to USD 498.0 million in 2026 and USD 1,095.0 million by 2036. FMI projects a CAGR of 8.9% during the forecast period. Operations upgrade feed formulations to mitigate pathogen pressure in high-density livestock housing. Procurement concentrates on verified yeast derivatives that bind enteric bacteria and support mucosal immunity without requiring veterinary prescriptions.
Disease shocks accelerate demand for gut-health interventions, shifting specifications to carbohydrate-based binding agents. 267 poultry outbreaks resulting in 4.73 million culled birds reported in November 2025 compel operators to substitute standard diets with immunity-enhancing formulations [10]. Suppliers respond by increasing industrial fermentation capacity to ensure continuous availability. Sourcing strategies pivot from fragmented spot markets toward long-term contracts with integrated yeast producers to secure stable pricing.
-market-market-value-analysis.webp "Mannan Oligosaccharides (mos) Market Market Value Analysis")
Dr. Richard Murphy, director of research at Alltech, stated that “The microbiome plays a crucial role in nutrient absorption, immune function and disease resistance. By incorporating targeted dietary biotics into pet nutrition, we can positively influence gut health, mitigate the effects of harmful pathogens and improve overall pet wellbeing.” [7]
Across Asia Pacific and North America, growth concentrates where high-volume poultry operations align with intensive biosecurity protocols. India records a 10.1% CAGR, China expands at 9.6%, the United States posts 9.0%, the United Kingdom registers 8.5%, Brazil sees 8.4%, and Germany tracks at 8.2%. Regional dispersion mirrors feed mill concentration, as centralized manufacturing hubs integrate bio-active fractions into mass-market broiler and swine rations.
| Metric | Details |
|---|---|
| Industry Size (2026) | USD 498.0 million |
| Industry Value (2036) | USD 1,095.0 million |
| CAGR (2026-2036) | 8.9% |
The industry comprises the industrial synthesis, formulation, and commercial distribution of complex carbohydrate complexes extracted primarily from Saccharomyces cerevisiae. Operations quantify total revenue generated from bulk powder and liquid additive sales directly integrated into animal nutrition matrices. Suppliers formulate these fractions to bind Gram-negative pathogens and modulate immune responses in monogastric and ruminant digestive tracts. Procurement metrics rely on inclusion rates per ton of finished feed across commercial production cycles. Adopting targeted animal feed prebiotics improves feed conversion ratios while aligning with global antimicrobial reduction targets.
The Mannan-oligosaccharides (MOS) category includes revenues generated from purified MOS extracted from primary-grown yeast cultures, where mannose-rich fractions serve as the principal functional component. It covers hybrid yeast cell wall complexes standardized for MOS content and sold through direct integrator agreements and specialized agricultural distribution channels. Commercial volumes designated for aquaculture, companion animals, and livestock feed inclusion fall within scope.
The scope excludes unprocessed whole yeast, spent yeast, or dried distiller grains that lack quantified carbohydrate extraction or standardized MOS concentration. It does not include human dietary supplements or pharmaceutical applications derived from yeast fractions. Competing prebiotic compounds such as inulin or synthetic oligosaccharides are excluded, as are finished retail meat or dairy products marketed with functional feed positioning.
-market-analysis-by-source.webp "Mannan Oligosaccharides (mos) Market Analysis By Source")
Yeast derived raw materials remain the preferred foundation for MOS production because feed manufacturers prioritize consistent biological activity and reliable pathogen binding performance in commercial use. This sourcing preference keeps yeast cell walls in a dominant position with 69% of market share in 2026. As per FMI's projection, yeast cell walls dictate raw material sourcing strategies because synthetic alternatives fail to replicate the complex structural binding sites required for in vivo performance. Procurement relies on scalable fermentation platforms to guarantee active compound concentration. The transition from brewer yeast byproducts to primary cultivated strains elevates production costs but secures necessary quality assurances for major integrators. Buyers integrate these fractions to stabilize gut flora and reduce mortality rates under commercial stress conditions.
-market-analysis-by-application.webp "Mannan Oligosaccharides (mos) Market Analysis By Application")
Animal Feed constitutes 58% of global consumption in 2026, anchored by massive volumetric throughput in commercial farming. Formulators blend functional carbohydrates into base rations to proactively manage herd health and optimize nutrient absorption. FMI analysts opine that livestock integrators prioritize active inclusion rates to offset the performance penalties associated with antibiotic withdrawal. The sheer scale of global pellet and mash manufacturing provides an immense addressable base for specialized additives. Upgrading feed formulations with targeted prebiotics improves average daily weight gain and lowers overall veterinary expenditures. Procurement teams evaluate additive suppliers based on thermal stability during the pelleting process and verifiable in vivo trials.
-market-analysis-by-end-use.webp "Mannan Oligosaccharides (mos) Market Analysis By End Use")
Intensive poultry and livestock systems remain the core demand base for MOS because enteric risk control and feed conversion performance are directly tied to profitability in commercial protein production. Reflecting this concentration Livestock and Poultry capture 44% of total segment share in 2026. As per FMI's projection, animal feed constitutes the primary conversion path as poultry integrators mandate specific carbohydrate inclusion to sustain feed conversion metrics. Broiler and layer operations consume the highest volumes due to short production cycles and strict retailer welfare standards. Procurement specifies heat-stable yeast fractions capable of surviving aggressive conditioning temperatures. Swine operators represent a secondary growth pool, deploying these compounds to manage post-weaning stress and stabilize maternal microbiomes.
-market-analysis-by-distribution-channel.webp "Mannan Oligosaccharides (mos) Market Analysis By Distribution Channel")
Specialty Feed & Pharmaceutical Distributors account for 42% of the market in 2026, serving as the critical technical bridge between chemical extractors and independent farms. These entities bundle active compounds into complex premixes, providing essential formulation expertise to mid-sized milling operations. According to FMI's estimates, the structural transition toward specialized handlers occurs because pure yeast fractions require precise dosing protocols. Distributors aggregate demand across fragmented regional markets, creating predictable volume off-take for upstream manufacturers. Value-added services, including veterinary consulting and customized trial designs, secure distributor loyalty. Buyers rely on these channels to navigate complex regulatory landscapes and source certified antibiotic alternatives.
-market-opportunity-matrix-growth-vs-value.webp "Mannan Oligosaccharides (mos) Market Opportunity Matrix Growth Vs Value")
Intensifying biosecurity risks and the persistent threat of viral outbreaks compel global farming operations to mandate preventive nutritional protocols. High-pathogenicity events disrupt production cycles and inflict severe economic damage on integrated systems. Operations transition from reactive treatments to proactive mucosal immunity enhancement, heavily utilizing complex carbohydrates to bind opportunistic bacteria. The necessity to secure feed conversion ratios during biological stress periods forces formulation directors to standardise yeast cell wall inclusion. Procurement teams bypass temporary spot-market purchases in favor of annual supply contracts with certified specialty yeast processors.
Supply chain consolidation and the capital-intensive nature of advanced fermentation constrain broad market accessibility and elevate baseline unit costs. Producing high-purity mannose fractions requires sophisticated enzymatic separation and massive industrial bioreactors, creating steep barriers to entry for regional suppliers. This structural bottleneck concentrates pricing power among a few global yeast extract conglomerates, exposing mid-sized feed mills to sudden cost fluctuations. Buyers mitigate this exposure by diluting pure fractions with generic carriers or adopting phased inclusion protocols during peak stress periods. The 2024 divestment of dsm-firmenich's yeast extract business to Lesaffre illustrates this aggressive upstream consolidation, narrowing the vendor field and forcing buyers to accept standardized pricing models [11].
Based on the regional analysis, the Mannan-oligosaccharides (MOS) market is segmented into North America, Latin America, Europe, East Asia, South Asia, Oceania and Middle East & Africa across 40+ countries. The full report also offers market attractiveness analysis based on regional trends.
-market-cagr-(2026-2036).webp "Top Country Growth Comparison Mannan Oligosaccharides (mos) Market Cagr (2026 2036)")
| Country | CAGR (2026 to 2036) |
|---|---|
| India | 10.1% |
| China | 9.6% |
| United States | 9.0% |
| United Kingdom | 8.5% |
| Brazil | 8.4% |
| Germany | 8.2% |
Source: Future Market Insights (FMI) analysis, based on proprietary forecasting model and primary research
-market-cagr-analysis-by-country.webp "Mannan Oligosaccharides (mos) Market Cagr Analysis By Country")
North American demand relies on immense domestic protein production and the progressive integration of functional additives by massive commercial cooperatives. FMI analysts opine that volume expansion across this region aligns with large-scale processing requirements, pushing integrators to standardize biological gut-health protocols. Operations mandate verifiable improvements in average daily gain to offset rising raw material costs. Procurement teams secure long-term contracts with regional fermentation facilities to minimize import reliance and guarantee uninterrupted supply.
FMI's report includes a detailed growth analysis and country-wise assessment of the North American landscape. Canada and Mexico emerge as critical opportunistic markets as cross-border meat trade standardizes feeding protocols. Buyers monitor the deployment of synbiotic animal feed formulations across these territories to align with export-grade residue limits.
-market-europe-country-market-share-analysis,-2026-&-2036.webp "Mannan Oligosaccharides (mos) Market Europe Country Market Share Analysis, 2026 & 2036")
European consumption is characterized by strict regulatory enforcement regarding antimicrobial usage and intense retailer pressure concerning animal welfare. As per FMI's projection, antibiotic-reduction norms mandate preventive nutrition, shifting procurement entirely toward verified biological and carbohydrate-based alternatives. Operations face high scrutiny over production inputs, forcing complete transparency in additive sourcing. Total feed mill capacity shows signs of structural rationalization, concentrating purchasing power among fewer, highly sophisticated integrators.
FMI's report includes a detailed growth analysis and country-wise assessment of the European sector. France and Spain present significant upside as their massive poultry industries modernize to combat viral threats. Operators deploying animal feed probiotics track changing regulatory benchmarks to maintain compliance in these vital production zones.
-market-country-value-analysis.webp "Mannan Oligosaccharides (mos) Market Country Value Analysis")
Asia Pacific operates as the global engine for volumetric growth, driven by rapid industrialization of traditional farming and immense population-led protein demand. Operations upgrade from backyard models to high-density commercial facilities, necessitating the immediate integration of robust gut-health additives. Procurement scales rapidly to supply massive localized milling hubs, reducing reliance on outdated medication practices. Feed manufacturers seek cost-effective, domestic fermentation sources to shield themselves from currency fluctuations while maintaining baseline flock immunity during unpredictable disease cycles.
FMI's report includes a detailed growth analysis and country-wise assessment covering the entire Asia Pacific territory. Japan and Australia demonstrate steady replacement demand driven by premium quality specifications. Feed formulators utilizing a prebiotic ingredient monitor advanced fermentation technologies deployed in these nations to replicate high-yield outcomes.
Latin America leverages its position as a primary global meat exporter, utilizing advanced nutritional protocols to meet stringent international quality standards. Operations deploy functional carbohydrates to maintain feed conversion efficiency and protect high-volume poultry and swine operations from environmental stress. Procurement aligns with massive integrated forestry and agricultural conglomerates to ensure continuous, cost-effective additive supply. Major yeast extraction facilities localize production to serve these hubs, reducing transit costs and ensuring fresh, highly active biological compounds for export-oriented meat producers.
FMI's report includes a detailed growth analysis and country-wise assessment spanning Latin American markets. Argentina and Chile represent key expansion frontiers as their commercial aquaculture and poultry sectors mature. Integrators combining fructo oligosaccharides with specialized yeast fractions watch Brazilian export standards to optimize their own feed formulations.
-market-analysis-by-company.webp "Mannan Oligosaccharides (mos) Market Analysis By Company")
Upstream consolidation is changing how reliably feed additive supplies move through the market, and feed mills are being pushed to rethink procurement practices. As per FMI's projection, the separation of core business units disrupts historical purchasing channels, requiring buyers to qualify new primary vendors.
Securing large-scale fermentation assets neutralizes regional price volatility and guarantees high-purity extraction capabilities. Manufacturers acquiring established biological facilities gain immediate access to proprietary yeast strains and advanced enzymatic refining equipment. Lesaffre's 2024 acquisition of a 70% stake in Biorigin expands its global yeast derivative footprint, allowing the company to dictate baseline pricing and capture lucrative multi-year supply contracts across the Americas [12].
Integrated distribution networks dictate the pace of new product adoption by bundling specialized additives with bulk feed deliveries. Joint ventures combining scientific formulation with vast logistical reach capture dominant market shares in fragmented regions.
The report includes full coverage of key trends from competitive benchmarking. Some of the recent developments covered in the reports:
-market-breakdown-by-source,-application,-and-region.webp "Mannan Oligosaccharides (mos) Market Breakdown By Source, Application, And Region")
| Metric | Value |
|---|---|
| Quantitative Units | USD 498.0 million (2026) to USD 1,095.0 million (2036), at a CAGR of 8.9% |
| Market Definition | The industry comprises the industrial synthesis, formulation, and commercial distribution of complex carbohydrate complexes extracted primarily from Saccharomyces cerevisiae, utilized to bind pathogens and modulate immunity in commercial livestock. |
| Source Segmentation | Yeast cell walls, Others |
| Application Segmentation | Animal Feed, Others |
| End User Segmentation | Livestock & Poultry, Others |
| Distribution Channel Segmentation | Specialty Feed & Pharmaceutical Distributors, Others |
| Regions Covered | North America, Latin America, Europe, East Asia, South Asia, Oceania, Middle East and Africa |
| Countries Covered | United States, Canada, Mexico, Brazil, Argentina, Germany, France, United Kingdom, Italy, Spain, China, India, Japan, South Korea, Indonesia, Australia and 40 plus countries |
| Key Companies Profiled | Lesaffre, ADM, Alltech, Biorigin, dsm-firmenich (CVC Capital Partners), Phileo by Lesaffre, Zilor, Lallemand Animal Nutrition, Kemin Industries, Novus International |
| Forecast Period | 2026 to 2036 |
| Approach | Hybrid top down and bottom up market modeling validated through primary interviews with yeast fermentation facility managers and regional feed mill operators, supported by official agricultural outputs and corporate divestment filings |
This bibliography is provided for reader reference and is not exhaustive. The full report contains the complete reference list and detailed citations.
How large is the demand for Mannan-oligosaccharides in the global market in 2026?
Demand for Mannan-oligosaccharides is estimated to be valued at USD 498.0 million in 2026.
What will be the market size of Mannan-oligosaccharides in the global market by 2036?
Market size is projected to reach USD 1,095.0 million by 2036.
What is the expected demand growth for Mannan-oligosaccharides in the global market between 2026 and 2036?
Demand is expected to grow at a CAGR of 8.9% between 2026 and 2036.
Which Source is poised to lead global sales by 2026?
Yeast cell walls lead with a 69% share, as verified extraction processes ensure dense binding sites for enteric pathogens.
How significant is the role of Animal Feed in driving Mannan-oligosaccharides adoption in 2026?
Animal Feed commands a 58% share, driven by massive volumetric integration across commercial poultry and swine rations.
What is driving demand in India?
Poultry sector modernization and expanding local premix distribution networks accelerate targeted biological deployments.
What compliance standards or regulations are referenced for India?
Intensive farming biosecurity protocols shape regional procurement of verified gut-health additives.
What is the India growth outlook in this report?
India is projected to grow at a CAGR of 10.1% during 2026 to 2036.
Why is North America described as a priority region in this report?
Massive domestic protein production requires standardized functional inputs to maintain conversion efficiency at commercial scale.
What type of demand dominates in North America?
High-volume integration demand led by consolidated milling groups and large-scale agricultural cooperatives dominates the region.
What is China growth outlook in this report?
China is projected to expand at a CAGR of 9.6% during 2026 to 2036.
Does the report cover United States in its regional analysis?
Yes, the United States is included within the North America regional scope.
What are the sources referred to for analyzing United States?
USDA meat production statistics and corporate joint venture announcements inform the domestic commercial outlook.
What is the main demand theme linked to United States in its region coverage?
Procurement relies on localized milling hubs capable of integrating specialized additives to support immense red meat and poultry outputs.
Does the report cover United Kingdom in its regional analysis?
Yes, the United Kingdom is included within the Europe regional coverage framework.
What is the main United Kingdom related demand theme in its region coverage?
Strict antibiotic reduction norms and retailer welfare pressures dictate total reliance on biological alternatives.
Which product formats or configurations are strategically important for Asia Pacific supply chains?
Stable bulk powder fractions are critical for uniform blending across expanding rural feed mill networks.
What is Mannan-oligosaccharides and what is it mainly used for?
It is a complex yeast-derived carbohydrate used primarily to bind harmful bacteria and boost mucosal immunity in commercial livestock.
What does Mannan-oligosaccharides mean in this report?
The scope strictly covers commercial volumes of purified fractions used directly within animal nutrition matrices.
What is included in the scope of this Mannan-oligosaccharides report?
Revenues from extracted cell walls, hybrid complexes, and bulk formulations distributed to livestock operators are fully included.
What is excluded from the scope of this report?
Human dietary supplements, generic whole yeast without quantified fractions, and competing synthetic oligosaccharides are omitted.
What does market forecast mean on this page?
It represents a model-based projection built on verifiable feed tonnage outputs and fermentation capacities for strategic planning.
How does FMI build and validate the Mannan-oligosaccharides forecast?
A hybrid model multiplies available feed tonnage by inclusion rates, validated against primary fermentation capacity checks.
What does zero reliance on speculative third party market research mean here?
Forecasts stem directly from primary facility consultations and official agricultural databases rather than unverified syndicated estimates.
Full Research Suite comprises of:
Market outlook & trends analysis
Interviews & case studies
Strategic recommendations
Vendor profiles & capabilities analysis
5-year forecasts
8 regions and 60+ country-level data splits
Market segment data splits
12 months of continuous data updates
DELIVERED AS:
PDF EXCEL ONLINE
Mannan-oligosaccharides (MOS) Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
